MRS. LINSEY PAILO ITTYIPE FNP-C NPI 1558993733

NPI Details

MRS. Linsey Pailo Ittyipe, FNP-C is a family nurse practitioner in Bellaire, TX with 10 years of experience. MRS. Linsey Pailo Ittyipe, FNP-C NPI is 1558993733. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

4710 BELLAIRE BLVD STE 340
BELLAIRE, TX
ZIP 77401-530
Phone: (713) 218-0691

The NPI 1558993733 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, ocrelizumab, 1 mg (HCPCS:J2350)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, vedolizumab, 1 mg (HCPCS:J3380)
• Injection, mepolizumab, 1 mg (HCPCS:J2182)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, omalizumab, 5 mg (HCPCS:J2357)
• Injection, tildrakizumab, 1 mg (HCPCS:J3245)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, benralizumab, 1 mg (HCPCS:J0517)
• Ustekinumab, for subcutaneous injection, 1 mg (HCPCS:J3357)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)

The enumeration date for this NPI number is 2/6/2020 and was last updated on 2/6/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: